Portfolio Design Labs’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Portfolio Design Labs's BMY Position: Q3 2026 in Review
Portfolio Design Labs increased its Bristol-Myers Squibb (BMY) stake by 0.37% in Q3 2026, buying an estimated $2.91K and bringing the position to 12,340 shares worth $770K. The position accounts for 0.12% of the portfolio, ranked #135.
Portfolio Design Labs first reported a position in BMY in Q3 2024 and has held it in 9 quarters since. The position peaked at $3.08M in Q1 2025. 2,533 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Portfolio Design Labs held 12,340 shares of Bristol-Myers Squibb worth $770K as of Q3 2026.
- Portfolio Design Labs bought 46 Bristol-Myers Squibb shares in Q3 2026, an estimated $2.91K.
- Bristol-Myers Squibb made up 0.12% of Portfolio Design Labs's portfolio in Q3 2026, its #135 holding.
- Portfolio Design Labs first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 9 quarters since.
- Portfolio Design Labs's Bristol-Myers Squibb position peaked at $3.08M in Q1 2025.
- 2,533 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Portfolio Design Labs's 13F filing for Q3 2026, filed 4 Nov 2026.